MUFG Securities Americas’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$745K Buy
10,637
+1,015
+11% +$52.5K 0.04% 352
2026
Q1
$489K Buy
9,622
+255
+3% +$11.9K 0.03% 400
2025
Q4
$276K Buy
9,367
+29
+0.3% +$788 0.02% 475
2025
Q3
$241K Buy
9,338
+1,796
+24% +$50.1K 0.02% 479
2025
Q2
$208K Buy
7,542
+1,548
+26% +$40.8K 0.02% 472
2025
Q1
$170K Buy
5,994
+994
+20% +$35.3K 0.02% 470
2024
Q4
$208K Buy
+5,000
New +$239K 0.03% 439

Other funds holding MRNA

MUFG Securities Americas's MRNA Position: Q2 2026 in Review

MUFG Securities Americas increased its Moderna (MRNA) stake by 11% in Q2 2026, buying an estimated $52.5K and bringing the position to 10,637 shares worth $745K. The position accounts for 0.04% of the portfolio, ranked #352.

MUFG Securities Americas first reported a position in MRNA in Q4 2024 and has held it in 7 quarters since. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • MUFG Securities Americas held 10,637 shares of Moderna worth $745K as of Q2 2026.
  • MUFG Securities Americas bought 1,015 Moderna shares in Q2 2026, an estimated $52.5K.
  • Moderna made up 0.04% of MUFG Securities Americas's portfolio in Q2 2026, its #352 holding.
  • MUFG Securities Americas first reported a position in Moderna in Q4 2024 and has held it in 7 quarters since.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on MUFG Securities Americas's 13F filing for Q2 2026, filed 14 Aug 2026.